On Friday, Apple Inc. (NASDAQ:AAPL), showed bullish trend with higher momentum of 3.32% to close at $119.03. The company traded total volume of 57.77 shares as contrast to its average volume of 43.33 shares. The company has a market value of $663.63 and about 5.58 shares outstanding. During the 52-week trading session the minimum price at which share price traded, registered at $92.00 and reached to max level of $134.54.
In the trailing twelve months, net profit margin of the company was 22.80% while gross profit margin was 40.10%. The company has 2.84 value in price to sale ratio while price to book ratio was recorded as -5.63. The company earned $53.39 billion in prior twelve months on revenue of $233.72 billion. Apple Inc. (NASDAQ:AAPL) designs, manufactures and markets mobile communication and media devices, personal computers, and portable digital music players, and a variety of related software, services, peripherals, networking solutions, and third-party digital content and applications.
Shares of CVS Health Corp (NYSE:CVS), inclined 2.81% to $95.46, during its last trading session. CVS Health Corp (NYSE:CVS) opened its trading session at $93.28. During the trading session the minimum price at which share price traded, recorded at $81.37 and share price hit to max level of $113.65. It has market worth of $105.70. It traded total volume of 5.17 shares /lower than the average volume of 6.33 shares.
In the last 12 months, CVS Health Corp (NYSE:CVS) EPS was booked as $4.45. 85.70% shares of the company were owned by institutional investors. In the profitability analysis, the company has gross profit margin of 17.30% while net profit margin was 3.40%. Beta value of the company was 0.89; beta is used to measure riskiness of the security. CVS Health Corp (NYSE:CVS) is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.
Mylan NV (NASDAQ:MYL) closed at $51.41 with trading volume of 5.22 shares up its average volume of 9.75. The company fell 0.67% with market capitalization of 25.28. The stock’s institutional ownership stands at 81.50%. During the year, the lowest price at which share is traded was $50.15 and hit the highest price at $52.41.
The share price is going higher than to its 52 week low with 36.77% while its 52 week high with -32.96%. Beta factor, which is used to measure risk associated with the stock, is stands at 1.32. The company offered net profit margin of 9.30% while its gross profit margin was 46.10%. ROE was recorded as 10.60%. Mylan NV (NASDAQ:MYL) is a global pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. Mylan operates in two segments: Generics and Specialty.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.